Acarix A/S - Asset Resilience Ratio
Acarix A/S (ACARIX) has an Asset Resilience Ratio of 37.81% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Acarix A/S to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Acarix A/S's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Acarix A/S total assets.
Liquid Assets Composition Over Time
This chart breaks down Acarix A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ACARIX total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr18.27 Million | 37.81% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr18.27 Million | 37.81% |
Asset Resilience Insights
- Very High Liquidity: Acarix A/S maintains exceptional liquid asset reserves at 37.81% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Acarix A/S Industry Peers by Asset Resilience Ratio
Compare Acarix A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Acarix A/S (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Acarix A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.19% | Skr152.00K ≈ $16.36K |
Skr80.76 Million ≈ $8.69 Million |
-0.05pp |
| 2023-12-31 | 0.23% | Skr147.00K ≈ $15.82K |
Skr62.88 Million ≈ $6.77 Million |
-16.04pp |
| 2022-12-31 | 16.28% | Skr11.31 Million ≈ $1.22 Million |
Skr69.48 Million ≈ $7.48 Million |
+2.79pp |
| 2021-12-31 | 13.49% | Skr16.00 Million ≈ $1.72 Million |
Skr118.60 Million ≈ $12.76 Million |
+13.27pp |
| 2020-12-31 | 0.22% | Skr195.00K ≈ $20.99K |
Skr89.95 Million ≈ $9.68 Million |
-0.07pp |
| 2019-12-31 | 0.28% | Skr234.00K ≈ $25.18K |
Skr82.98 Million ≈ $8.93 Million |
-68.19pp |
| 2018-12-31 | 68.48% | Skr65.19 Million ≈ $7.02 Million |
Skr95.20 Million ≈ $10.24 Million |
-8.79pp |
| 2017-12-31 | 77.27% | Skr103.58 Million ≈ $11.15 Million |
Skr134.06 Million ≈ $14.43 Million |
-6.97pp |
| 2016-12-31 | 84.24% | Skr145.97 Million ≈ $15.71 Million |
Skr173.29 Million ≈ $18.65 Million |
+83.89pp |
| 2015-12-31 | 0.35% | Skr54.00K ≈ $5.81K |
Skr15.58 Million ≈ $1.68 Million |
-- |
About Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Au… Read more